BOSTON, April 3, 2019 /PRNewswire-PRWeb/ -- KICVentures announced today the issuance of a patent for SpineFrontier's
The LESplasty system allows for straightforward implantation and minimization of tissue disruption when used with SpineFrontier's patented LESplasty inserter technology.
"The issuance of our LESplasty patent demonstrates SpineFrontier's commitment to providing superior patient care while strengthening our product portfolio with leading industry technologies," said SpineFrontier Director of Innovation, Vito Lore.
"Less Exposure Surgery (LESŪ) is based on a new philosophy of performing surgery," says Professor Kingsley R. Chin, M.D, Founder of LES. "All surgeries begin with maximal exposure but evolve to less exposure. LESŪ is less invasive than MIS. By developing improved technologies and techniques tailored to pinpointing a problem and fixing it without collateral damage, LESŪ minimizes tissue disruption."
SpineFrontier is a medical device technology company founded in 2006 that designs and develops proprietary, best-in-class implants and instruments for spine surgery based on the trademarked Less Exposure Surgery (LES (TM)) philosophy. SpineFrontier is a KICVentures' portfolio company and the leader in LES (TM) technologies.
KICVentures is a private investment holding company founded by Harvard-trained Orthopedic Surgeon & Professor Dr. Kingsley R. Chin, who brings unique experience at the intersection of medicine, business and information technology. KICVentures is equipped with a strong advantage in identifying niche healthcare opportunities and has a proven track-record of building the most disruptive spine technology portfolio, including AxioMed, NanoFUSE and SpineFrontier. It has headquarters in Boston, MA.
Subscribe to our Free Newsletters!